Paul J. Clancy
2014
In 2014, Paul J. Clancy earned a total compensation of $4.7M as EVP, Chief Financial Officer at Biogen, a 5% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $25,454 |
|---|---|
| Non-Equity Incentive Plan | $811,632 |
| Salary | $698,389 |
| Stock Awards | $2,824,497 |
| Other | $330,045 |
| Total | $4,690,017 |
Clancy received $2.8M in stock awards, accounting for 60% of the total pay in 2014.
Clancy also received $25.5K of change in pension value and nonqualified deferred compensation earnings, $811.6K in non-equity incentive plan, $698.4K in salary and $330K in other compensation.
Rankings
In 2014, Paul J. Clancy's compensation ranked 1,713th out of 13,032 executives tracked by ExecPay. In other words, Clancy earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,713 out of 13,032 | 87th |
Division Manufacturing | 612 out of 4,966 | 88th |
Major group Chemicals And Allied Products | 192 out of 1,686 | 89th |
Industry group Drugs | 149 out of 1,365 | 89th |
Industry Biological Products, Except Diagnostic Substances | 21 out of 236 | 91st |
Source: SEC filing on April 15, 2016.
Clancy's colleagues
We found seven more compensation records of executives who worked with Paul J. Clancy at Biogen in 2014.
2014
George Scangos
Biogen
Chief Executive Officer
2014
Alfred Sandrock
Biogen
Chief Medical Officer
2014
Adriana Karaboutis
Biogen
EVP, Technology and Business Solutions
2014
Adam Koppel
Biogen
SVP, Chief Strategy Officer
2014
Douglas Williams
Biogen
Former EVP, Research and Development
2014
John Cox
Biogen
EVP, Pharmaceutical Operations and Technology
2014
Stuart Kingsley
Biogen